Leading Global CRDMO Enabling Pharmaceutical Innovation Worldwide

WuXi AppTec

Integrated End-to-End CRDMO Platform

Our Vision

Every Drug Can Be Made and Every Disease Can Be Treated.

Our Values

Integrity & Dedication, Working Together & Sharing Success; Doing the Right Thing, Doing It Right.

About us

Enabling Innovation

WuXi AppTec is a trusted partner and contributor to the pharmaceutical and life sciences industries, providing R&D and manufacturing services that help advance healthcare innovation. With operations across Asia, Europe, and North America, we offer integrated, end-to-end services through our unique CRDMO (Contract Research, Development, and Manufacturing Organization) platform. We are privileged to work alongside partners across 30+ countries, supporting their efforts to bring breakthrough treatments to patients. Guided by our vision that every drug can be made and every disease can be treated, we are committed to advancing breakthroughs for patients—one collaboration at a time.

Foster Collaboration with Innovative Solutions

An Integrated CRDMO Business Model

Supporting our customers to deliver groundbreaking treatments to patients around the world

 
Research
 
Development
 
Manufacturing

Our Company

Empowering Health Innovation

Collaborating with partners to deliver comprehensive capabilities and innovative technologies in the pharmaceutical and healthcare industry

WuXi Chemistry

WuXi Chemistry

Provides CRDMO services for new drug development from discovery to commercial
SEE MORE >
WuXi Biology

WuXi Biology

A full spectrum of biology services and solutions supporting stand-alone and integrated projects
SEE MORE >
WuXi Testing

WuXi Testing

An integrated testing platform across the full life cycle of discovery and development to help customers deliver innovative medicines to patients.
SEE MORE >

News

Latest News about WuXi AppTec

WuXi AppTec Receives Double “A” Rating from CDP for Climate Change and Water Security Leadership

WuXi AppTec Receives Frost & Sullivan’s 2025 Global Company of the Year Award in the CRDMO Industry

WuXi AppTec Looks to Extend CRDMO Platform to Saudi Arabia as It Signs Strategic MoUs with NEOM and Ministry of Health

WuXi AppTec Achieves Strong Double-Digit Growth in Revenue and Profit for Q1-Q3 2025; Backlog for Continuing Operations Up 41.2% YoY; Further Raises 2025 Full-year Guidance

WuXi AppTec Awarded Gold Medal by EcoVadis Sustainability Rating for Second Consecutive Year

Careers

Join Our Team

Become Part of Creating a Better Life

Investors

Latest Financial Reports, Announcements and Resources